2LBA Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2

Publication date: February 2017
Source:European Journal of Cancer, Volume 72, Supplement 1
Author(s): G.S. Sonke, L.L. Hart, M. Campone, F. Erdkamp, W. Janni, S. Verma, C. Villanueva, E. Jakobsen, E. Alba, E. Wist, A.M. Favret, T. Bachelot, R. Hegg, P. Wheatley-Price, F. Souami, S. Sutradhar, M. Miller, C. Germa, H.A. Burris




http://ift.tt/2k08QMk